✦ LIBER ✦

Successful treatment of acute myelogenous leukemia with favorable cytogenetics by reduced-intensity stem cell transplantation

✍ Scribed by Takeshi Kondo; Atsushi Yasumoto; Kotaro Arita; Jun-ichi Sugita; Akio Shigematsu; Kohei Okada; Mutsumi Takahata; Masahiro Onozawa; Kaoru Kahata; Yukari Takeda; Masato Obara; Satoshi Yamamoto; Tomoyuki Endo; Mitsufumi Nishio; Norihiro Sato; Junji Tanaka; Satoshi Hashino; Takao Koike; Masahiro Asaka; Masahiro Imamura

Book ID: 107618938
Publisher: Carden Jennings Publishing
Year: 2010
Tongue: English
Weight: 393 KB
Volume: 91
Category: Article
ISSN: 0925-5710
DOI: 10.1007/s12185-009-0487-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute fulminant myocarditis after alloge

Acute fulminant myocarditis after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning for acute myelogenous leukemia

✍ Chiaki Nakaseko; Emiko Sakaida; Chikako Ohwada; Shinichi Ozawa; Masahiro Takeuch 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 96 KB

Cost and effectiveness of reduced-intens

Cost and effectiveness of reduced-intensity and conventional allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome

✍ Osamu Imataki; Takeshi Kamioka; Takashi Fukuda; Ryuji Tanosaki; Yoichi Takaue 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 163 KB

Reduced intensity conditioning prior to

Reduced intensity conditioning prior to allogeneic stem cell transplantation for patients with acute myeloblastic leukemia as a first-line treatment

✍ Didier P. Blaise; Jean Michel Boiron; Catherine Faucher; Mohamad Mohty; Jacques- 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

Successful treatment with reduced-intens

Successful treatment with reduced-intensity stem cell transplantation in a case of relapsed refractory central nervous system lymphoma

✍ Y. Aoyama; R. Yamamura; E. Shima; H. Nakamae; K. Makita; G. Kho; K. Ohta; T. Yam 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 222 KB

New sequential treatment with chemothera

New sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem-cell transplantation in very high-risk acute myeloid leukemia

✍ Thomas Cluzeau; Muriel De Matteis; Nicolas Mounier; Lionel Mannone; Nicole Grate 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 659 KB

Comparison of allogeneic stem cell trans

Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia

✍ Apostolia-Maria Tsimberidou; Niki Stavroyianni; Nora Viniou; Maria Papaioannou; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

## Abstract ## BACKGROUND Postremission therapy is critical in maintaining complete remission (CR) in patients with de novo acute myelogenous leukemia (AML). The aim of this trial was to compare allogeneic stem cell transplantation (SCT), high‐dose cytarabine (ara‐C; HiDAC), and autologous SCT as